This is one of the questions I get asked most directly, usually by a patient who's done well on treatment and is wondering what happens if they stop. I think the honest answer deserves more attention than it usually gets, because the data on this has become considerably clearer in the last couple of years, and it's not the answer most patients are hoping for.
What the trial data actually shows
The clearest picture comes from formal withdrawal studies — trials specifically designed to follow patients after they stop treatment, rather than just assuming what happens.
In the STEP 1 extension trial, patients who stopped semaglutide regained roughly two-thirds of their lost weight within a year of discontinuation. By the end of that trial, the group that had stopped the medication had regained an average of 11.6 percentage points of the weight they'd lost, compared to just 1.9 percentage points in patients who'd never lost the weight in the first place — meaning the net benefit from the entire treatment period shrank from a substantial loss down to a modest 5.6% by the end.
SURMOUNT-4, the equivalent trial for tirzepatide, found something similar: patients who switched from tirzepatide to a placebo after 36 weeks of treatment regained an average of 14% of their body weight over the following year, while patients who stayed on the medication continued losing weight during that same period. A more recent post-hoc analysis of that same trial, published in late 2025, found that most participants who stopped tirzepatide had regained at least a quarter of their lost weight within a year — and importantly, the degree of regain directly tracked with how much of the cardiometabolic benefit was lost along with it. Patients who regained more weight lost more of the blood pressure, cholesterol, and blood sugar improvements they'd gained during treatment.
Why this happens
None of this is really about willpower reasserting itself, which is a framing I've pushed back on throughout this site. GLP-1 medications work by influencing appetite-regulating hormones directly. When the medication stops, those hormonal effects fade — for most of these drugs, within a matter of weeks, given how they're metabolized — and the underlying appetite regulation that was disrupted before treatment tends to return to roughly where it was.
This is genuinely similar to the physiology I described in the post on bariatric surgery patients who regain weight — hormonal effects that partially reverse over time, sometimes compounded by muscle loss that occurred during the weight-loss phase, which lowers the resting metabolic rate a person needs to maintain their new weight. The mechanism is pharmacological rather than surgical, but the underlying pattern is strikingly similar: this is physiology, not a moral failure of discipline.
Why muscle preservation matters even more here
This is where the muscle-preservation stack I described a few posts back becomes directly relevant to the discontinuation question specifically. A patient who loses weight on a GLP-1 while also losing a meaningful share of muscle mass ends up with a lower metabolic baseline than someone who preserved muscle throughout treatment. That lower baseline means fewer calories are needed to maintain the new weight — which, when appetite regulation partially reverts after stopping medication, makes regain both more likely and potentially faster. Preserving muscle during treatment isn't just about looking and feeling better. It's a real hedge against how sharply this specific transition can go.
What this means for how discontinuation should actually happen
Given this data, I think about stopping GLP-1 therapy as something that should be planned and discussed, not something that happens abruptly or without a real conversation about what to expect. A few things I'd want every patient to know going into that conversation:
Obesity is increasingly understood as a chronic condition requiring ongoing management, not a problem that gets permanently solved and then closed out. This framing, echoed by researchers across several of these trials, matters because it reframes the goal — the aim was never to "graduate" off treatment the way you might finish a course of antibiotics.
The degree of regain isn't all-or-nothing. The post-hoc analysis I mentioned found that cardiometabolic benefit loss tracked with how much weight came back — meaning partial maintenance after stopping still preserves partial benefit. This isn't a reason to stop carelessly, but it's a reason not to view any regain as a total loss of everything gained.
If discontinuation is being considered — for cost, side effects, personal preference, or any other reason — it deserves the same planning that starting treatment did. That includes an honest conversation about expected regain, a realistic plan for maintaining the nutrition and resistance training habits built during treatment, and close monitoring afterward rather than simply stopping and hoping for the best.
What I'd want you to take from this
If you're doing well on GLP-1 therapy and considering stopping, I'd want you to go into that decision with real information rather than optimism about willpower carrying you through. The data is fairly consistent across multiple trials now: most patients regain a substantial share of the weight within a year, and that regain tracks with losing some of the metabolic benefit that came with it. That doesn't mean discontinuation is never the right choice — it means it's a decision worth making deliberately, with a plan, rather than a default that happens when a prescription runs out.
Thinking about stopping GLP-1 therapy and want to talk through what to expect?
No spam. Occasional new posts and updates from The Center for Metabolic Health.
Medical disclaimer: This content is provided for general educational and informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any condition, and it does not create a physician-patient relationship. Every patient's medical history, health status, and treatment needs are different. Always consult your own physician or qualified healthcare provider before starting, stopping, or changing any medication or treatment, and before making any decisions based on information found here. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.